Dr Reddy’s North America head quits
Umang Vohra was previously Dr Reddy's Laboratories's Chief Financial Officer in India
Dr Reddy’s Laboratories North America head…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
DRL recalls Rivastigmine Tartrate capsules from US
A total of 60 bottles of 2952 units are recalled on the direction of US FDA
DRL launches Pramipexole dihydrochloride extended-release tablets in US
The tablets are available in 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in bottle count sizes of 30
Dr Reddy’s Laboratories (DRL)…
DRL in collaboration with Amgen in India
DRL to market and distribute Amgen’s Repatha, Kyprolis and BLINCYTO in India upon approval
Dr Reddy’s Laboratories (DRL) has…
DRL posts consolidated revenues of Rs 37.6 billion, showing seven per cent growth YoY
Gross profit margin were at 61.1 per cent
DRL announces launch of memantine hydrochloride tablets, USP
It is a therapeutic equivalent generic version of NAMENDA (memantine HCl) tablets in the US market
DRL files Annual Report on Form 20-F
The report was filed with the United States Securities and Exchange Commission recently
DRL in agreement with AstraZeneca Pharma India for Riax and Riax M
DRL will be distributing Riax and Riax M in India
Dr Reddy’s Laboratories (DRL) and AstraZeneca Pharma India have entered into a…
Satish Reddy appointed as Chairman of National Safety Council
He will take over the Chairmanship from Venu Srinivasan, who steered the workings of the Council since July 2011
DRL launches Somazina for stroke patients in India
Partners with global innovator of Citicoline, Ferrer Internacional, Spain, to make Somazina available in India